Suyash Prasad, MBBS, M.Sc., MRCP, MRCPCH, FFPM
Chief Medical Officer and Head of Research and Development
Pediatric Intensivist with 20 years in the biopharmaceutical industry at Eli Lilly, Genzyme, BioMarin and, most recently, as SVP and CMO of gene therapy company Audentes Therapeutics.